KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-cash Items (2016 - 2025)

Historic Non-cash Items for TherapeuticsMD (TXMD) over the last 15 years, with Q3 2025 value amounting to $949000.0.

  • TherapeuticsMD's Non-cash Items rose 143064.52% to $949000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 316290.32%. This contributed to the annual value of $3.5 million for FY2024, which is 466986.3% up from last year.
  • Latest data reveals that TherapeuticsMD reported Non-cash Items of $949000.0 as of Q3 2025, which was up 143064.52% from -$164000.0 recorded in Q2 2025.
  • TherapeuticsMD's 5-year Non-cash Items high stood at $20.8 million for Q2 2021, and its period low was -$18.2 million during Q4 2022.
  • Moreover, its 5-year median value for Non-cash Items was $31035.0 (2024), whereas its average is $948615.0.
  • Per our database at Business Quant, TherapeuticsMD's Non-cash Items plummeted by 249270.83% in 2023 and then skyrocketed by 190704285.71% in 2025.
  • Quarter analysis of 5 years shows TherapeuticsMD's Non-cash Items stood at -$2.1 million in 2021, then plummeted by 748.09% to -$18.2 million in 2022, then skyrocketed by 81.23% to -$3.4 million in 2023, then soared by 97.16% to -$97000.0 in 2024, then skyrocketed by 1078.35% to $949000.0 in 2025.
  • Its Non-cash Items was $949000.0 in Q3 2025, compared to -$164000.0 in Q2 2025 and $1.3 million in Q1 2025.